VEGF and its receptor (VEGF-R) seem to be extremely important in tumor aggressiveness, because of their angiogenetic role: VEGF represents the target molecule of sorafenib, the most important anti-HCC drug developed in the last years. Here, KDR is linked to hepatocellular carcinoma.